Paper10073742
Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin.
Schäfers RF and 7 others. Br J Clin Pharmacol, 1999. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin. Papers, record 10073742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073742
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Antagonists | Major topic |
| Blood Pressure | Major topic |
| Prazosin | Major topic |
| Sulfonamides | Major topic |
| Vasoconstriction | Major topic |
| Adult | |
| Cross-Over Studies | |
| Drug Interactions | |
| Hemodynamics | |
| Humans | |
| Male | |
| Phenylephrine | |
| Placebos | |
| Single-Blind Method | |
| Tamsulosin |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5339656 | Development and evaluation of an impedance cardiac output system. | Aerosp Med | 1966 | https://conductscience.org/library/papers/5339656 | PubMed |
| 2 | 9720548 | Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability? | J Urol | 1998 | https://conductscience.org/library/papers/9720548 | PubMed |
| 3 | 4042526 | Terazosin kinetics after oral and intravenous doses. | Clin Pharmacol Ther | 1985 | https://conductscience.org/library/papers/4042526 | PubMed |
| 4 | 2872802 | Pharmacokinetics of terazosin. | Am J Med | 1986 | https://conductscience.org/library/papers/2872802 | PubMed |
| 5 | 1981137 | An evaluation of the alpha-adrenoceptor antagonism produced by SK&F 86466 in healthy normotensive males. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/1981137 | PubMed |
| 6 | 1683249 | Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects. | Br J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1683249 | PubMed |
| 7 | 1279214 | A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. | J Urol | 1992 | https://conductscience.org/library/papers/1279214 | PubMed |
| 8 | 7509243 | Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study Group. | Arch Fam Med | 1993 | https://conductscience.org/library/papers/7509243 | PubMed |
| 9 | 7858860 | Pharmacological evidence of distinct alpha 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery. | Br J Pharmacol | 1994 | https://conductscience.org/library/papers/7858860 | PubMed |
| 10 | 7881752 | Characterization of alpha 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/7881752 | PubMed |
| 11 | 7537194 | Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. | Drugs | 1995 | https://conductscience.org/library/papers/7537194 | PubMed |
| 12 | 7542819 | Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men. | Urology | 1995 | https://conductscience.org/library/papers/7542819 | PubMed |
| 13 | 7543612 | alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia. | J Urol | 1995 | https://conductscience.org/library/papers/7543612 | PubMed |
| 14 | 7670730 | Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/7670730 | PubMed |
| 15 | 7477417 | Classification of alpha 1-adrenoceptor subtypes. | Naunyn Schmiedebergs Arch Pharmacol | 1995 | https://conductscience.org/library/papers/7477417 | PubMed |
| 16 | 7491088 | Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure. | Life Sci | 1995 | https://conductscience.org/library/papers/7491088 | PubMed |
| 17 | 8607227 | The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group. | Urology | 1996 | https://conductscience.org/library/papers/8607227 | PubMed |
| 18 | 8647139 | Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. | Eur Urol | 1996 | https://conductscience.org/library/papers/8647139 | PubMed |
| 19 | 8647141 | Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. | Eur Urol | 1996 | https://conductscience.org/library/papers/8647141 | PubMed |
| 20 | 8692287 | Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction. | Naunyn Schmiedebergs Arch Pharmacol | 1996 | https://conductscience.org/library/papers/8692287 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21745239 | Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity? | Br J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21745239 | PubMed |
| 11950378 | Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. | Drugs Aging | 2002 | https://conductscience.org/library/papers/11950378 | PubMed |
| 11790159 | Tamsulosin: an update of its role in the management of lower urinary tract symptoms. | Drugs | 2002 | https://conductscience.org/library/papers/11790159 | PubMed |
| 11422021 | A 6-month large-scale study into the safety of tamsulosin. | Br J Clin Pharmacol | 2001 | https://conductscience.org/library/papers/11422021 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10073742
GET https://conductscience.org/api/papers/v1/10073742/references?page=2